Health Technology

Suzuken Co., Ltd.

In the news

Investors prodding cash-rich Japan Inc. to spend smarter Oct 4, 2017
AT&T to help Japan's Suzuken keep closer watch over costly meds Nov 4, 2016

Business Summary

Suzuken Co., Ltd. engages in the pharmaceutical business. It operates through the following segments: Pharmaceutical Wholesale, Pharmaceutical Manufacturing, Insurance Pharmacy, and Healthcare-related Services. The Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic reagents, medical equipment, and supplies. The Pharmaceutical Manufacturing segment manufactures and sells pharmaceuticals and diagnostic reagents. The Insurance Pharmacy segment prepares medicines based on prescriptions from medical institutions. The Healthcare-related Services segment includes medical book sales, medical device manufacturing, and drug transportation businesses. The company was founded by Kenzo Suzuki on November 13, 1932 and is headquartered in Nagoya, Japan.

Financial Highlights

Mar 2022	JPY	USD
Revenue	2,232.77B	19,869.36M
Gross Profit	160,994M	1,432.67M
Operating income	13,778M	122.60M
Income before tax	22,484M	200.08M
Net income	14,394M	128.09M
EBITDA	23,797M	211.76M
Diluted EPS	163.18	1.45
Dividends Per Share	72	0.64
Total Assets	1,141.71B	9,406.52M
Total liabilities	723,653M	5,962.12M
Total equity	417,687M	3,441.29M
Operating cash flow	9,520M	84.71M
	Currency in JPY	Currency in USD

Historical Data

JPY | USD

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Revenue	2,124.01B	2,132.34B	2,213.53B	2,128.47B	2,232.77B
Gross Profit	187,512M	189,295M	194,124M	157,841M	160,994M
Operating income	19,737M	27,229M	32,572M	9,158M	13,778M
Income before tax	28,766M	45,479M	41,808M	12,557M	22,484M
Net income	18,821M	30,205M	28,213M	7,896M	14,394M
EBITDA	31,800M	38,788M	43,998M	19,466M	23,797M
Diluted EPS	198.21	322.72	310.26	88.51	163.18
Dividends Per Share	64	69	72	72	72
Total Assets	1,173.32B	1,189.23B	1,112.50B	1,114.42B	1,141.71B
Total liabilities	766,896M	787,611M	699,796M	696,508M	723,653M
Total equity	405,752M	400,775M	411,839M	417,048M	417,687M
Operating cash flow	98,066M	41,751M	-25,817M	15,602M	9,520M

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Revenue	19,164.21M	19,228.56M	20,358.85M	20,069.11M	19,869.36M
Gross Profit	1,691.85M	1,706.98M	1,785.44M	1,488.25M	1,432.67M
Operating income	178.07M	245.53M	299.57M	86.34M	122.60M
Income before tax	259.54M	410.10M	384.52M	118.39M	200.08M
Net income	169.81M	272.37M	259.48M	74.45M	128.09M
EBITDA	286.91M	349.77M	404.66M	183.54M	211.76M
Diluted EPS	1.78	2.91	2.85	0.83	1.45
Dividends Per Share	0.57	0.62	0.66	0.67	0.64
Total Assets	11,032.68M	10,744.34M	10,305.28M	10,085.25M	9,406.52M
Total liabilities	7,211.05M	7,115.78M	6,482.29M	6,303.24M	5,962.12M
Total equity	3,815.25M	3,620.86M	3,814.91M	3,774.19M	3,441.29M
Operating cash flow	884.81M	376.49M	-237.45M	147.10M	84.71M

Valuation Measures

Mar 2022
PER	22.24
ROA	1.27%
ROE	3.44%
Operating margin	0.61%
Profit margin	0.64%

Key executives

President & Representative Director: Shigeru Asano
Executive Officer & Compliance Manager: Asako Tomita
Manager-Business Administration: Masahiro Hamanaka
Director & Senior Managing Executive Officer: Hisashi Tamura
Director, Head-Internal Control & Audit: Chie Takahashi

Shareholders

Suzuken Co., Ltd. (14.8%)
Silchester International Investors LLP (9.2%)
Shionogi & Co., Ltd. (3.1%)
BESSHO YOSHIKI (2.9%)
IZAWA HISAYO (2.3%)
Nomura Asset Management Co., Ltd. (2.2%)
NAGAI CHIKA (2.2%)
BESSHO MASAKI (2.1%)
Kopernik Global Investors LLC (2.0%)
Suzuken Group Employee Stock Ownership Plan (1.8%)

Contact Details

Website:http://www.suzuken.co.jp
Address: 8 Higashi Kataha-machi, Higashi-Ku, Nagoya, 461-8701, Japan
Phone: +81.52.961.2331

Related Companies

S.D. Collabo Co., Ltd.
S-Care Mate Co., Ltd.
Life Medicom Co., Ltd.
Suzuken Restricted Stock Compensation Plan
Embrace Co., Ltd.
Suzuken Trust
Suzuken Medical Information Bank KK
Ryomo Iyakuhin KK
Nakano Yakuhin KK
Medicis KK
Suzuken Okinawa Yakuhin Co., Ltd.
Chugoku Farmacy KK
Astis Co., Ltd.
Akiyama Butsuryu Service KK
Sanki Wellbe KK
Owl Chozai KK
Suzuken Logicom Corp.
Pfercos Co., Ltd.
Suzuken Iwate Co., Ltd.
Kenzmedico Co., Ltd.
Sanki Corp.
Akiyama, Inc.
Pfercos KK
Jingu Yakuhin KK
Omori Yakuhin Co. Ltd.
Shoyaku Co., Ltd.
Okinawa Yakuhin
Sanki Co., Ltd. /Medical/
Suzuken Group Employee Stock Ownership Plan
Chuo Unyu Co., Ltd.

Competitors

Sienna Biopharmaceuticals, Inc.

Last Updated on 4 Oct, 2022